<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyJ. Guillermo Paez, Matthew Meyerson, William R. Sellers et al.|Science|2004Cited by 9.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosisRoss L. Levine, D. Gary Gilliland, Martha Wadleigh et al.|Cancer Cell|2005Cited by 3k
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase InhibitorsIngo K. Mellinghoff, Paul S. Mischel, Maria Y. Wang et al.|New England Journal of Medicine|2005Cited by 1.4k
Assessing the significance of chromosomal aberrations in cancer: Methodology and application to gliomaRameen Beroukhim, William R. Sellers, Gad Getz et al.|Proceedings of the National Academy of Sciences|2007Cited by 1.1k
High-throughput oncogene mutation profiling in human cancerRoman K. Thomas, Meenhard Herlyn, Alissa C. Baker et al.|Nature Genetics|2007Cited by 996